Apellis Pharmaceuticals shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Skandinaviska Enskilda Banken AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.5M | 26k | 58.74 |
| 2023-09-30 | $972k | 26k | 38.00 |
| 2023-06-30 | $2.7M | 29k | 91.13 |
| 2023-03-31 | $1.9M | 29k | 65.96 |
| 2022-12-31 | $1.6M | 31k | 51.71 |
| 2022-09-30 | $2.5M | 37k | 68.28 |
| 2022-06-30 | $1.7M | 37k | 45.23 |
| 2022-03-31 | $1.9M | 37k | 50.79 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB